Zobrazeno 1 - 10 of 28 pro vyhledávání: '"F G H, Hill"'
1
Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders
Autor: Chris Millar, N. Gill, N. Connor, James W. Ironside, Jonathan T. Wilde, G. Dolan, Mark Winter, Michael Makris, Christine A. Lee, F. G. H. Hill
Publikováno v: Haemophilia. 16:305-315
Summary. The appearance and rapid evolution ofBSE in UK cattle in the mid 1980s, with compel-ling data supporting variant Creutzfeldt–Jakobdisease (vCJD) as its human manifestation, pose apotentially severe threat to public health. Threeclinical ca
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2b3babb5d3005211844d8ea44b91a486
https://doi.org/10.1111/j.1365-2516.2010.02220.x
Zobrazit plný text záznamu
3
The incidence of factor VIII inhibitors in the United Kingdom, 1990-93
Autor: F. G. H. Hill, C. R. M. Hay, F. E. Preston, B. T. Colvin
Publikováno v: British Journal of Haematology. 89:908-910
Reports of all the factor VIII inhibitors arising in the United Kingdom in patients with haemophilia A during the years 1990-93 have been collated by the United Kingdom Haemophilia Centre Directors Organization. 32 new inhibitors were reported during
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2703612fe30e8c6c92a32677995108a6
https://doi.org/10.1111/j.1365-2141.1995.tb08435.x
Zobrazit plný text záznamu
4
Factor VIII Inhibitors in Mild and Moderate-severity Haemophilia A
Autor: Ian R. Peake, B. T. Colvin, F. E. Preston, E. P. Mauser Bunschoten, Charles R. M. Hay, F. G. H. Hill, R. Bagnall, N. Wasseem, Karin Fijnvandraat, G. White, E. Santagostino, C. A. Ludlam, Erik Berntorp, Carol K. Kasper
Publikováno v: Thrombosis and Haemostasis. 79:762-766
SummaryTwenty six patients with mild or moderate haemophilia A and inhibitors are described. The inhibitor was detected at a median age of 33 years, after a median of 5.5 bleeding episodes. This usually following intensive replacement therapy. The me
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c35e76f2941a71b96fa72ca28ce91591
https://doi.org/10.1055/s-0037-1615061
Zobrazit plný text záznamu
5
De novo mutation causing sporadic type 2A von Willebrancd's disease: report of three cases
Autor: F. G. H. Hill, M. S. Enayat, B. D. M. Theophilus, K. J. Pasi
Publikováno v: Haemophilia. 2:244-249
Summary. Chemical mismatch detection has been used to screen selectively part of the A2 domain of exon 28 of the von Willebrand factor gene of three unrelated patients with apparently sporadic type 2A von Willebrand disease (vWD) and their parents an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a746aaaec12248478724cf34f531049
https://doi.org/10.1111/j.1365-2516.1996.tb00145.x
Zobrazit plný text záznamu
6
Recommendations for the treatment of factor VIII inhibitors
Autor: F. E. Preston, Christopher A. Ludlam, Charles R. M. Hay, B. T. Colvin, F. G. H. Hill
Publikováno v: Blood Coagulation & Fibrinolysis. 7:134-138
A strategy is described for the initial detection, management and elimination of factor VIII inhibitors arising in patients with congenital and acquired haemophilia A. It is suggested that children with severe haemophilia A should be screened every 3
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c5c17968e6f03f83a9dbc70f43205956
https://doi.org/10.1097/00001721-199603000-00005
Zobrazit plný text záznamu
7
The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products
Autor: S M A, Zaman, F G H, Hill, B, Palmer, C M, Millar, A, Bone, A M, Molesworth, N, Connor, C A, Lee, G, Dolan, J T, Wilde, O N, Gill, M, Makris
Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia. 17(6)
The risk of variant Creutzfeldt-Jakob disease (vCJD) from potentially infected plasma products remains unquantified. This risk has been assessed for 787 UK patients with an inherited bleeding disorder prospectively followed-up for 10-20 years through
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::58caf53d42fa822f15ba8fdff5c6835c
https://pubmed.ncbi.nlm.nih.gov/21342369
Zobrazit plný text záznamu
10
Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders
Autor: C M, Millar, N, Connor, G, Dolan, C A, Lee, M, Makris, J, Wilde, M, Winter, J W, Ironside, N, Gill, F G H, Hill
Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia. 16(2)
The appearance and rapid evolution of BSE in UK cattle in the mid 1980s, with compelling data supporting variant Creutzfeldt-Jakob disease (vCJD) as its human manifestation, pose a potentially severe threat to public health. Three clinical cases and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::35df5e94c2c87fb4e6aa6f0a500d7b40
https://pubmed.ncbi.nlm.nih.gov/21362112
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje